Global Equine Immunoglobulin and F(ab')2 Products Supply, Demand and Key Producers, 2026-2032
The global Equine Immunoglobulin and F(ab')2 Products market size is expected to reach $ 1971 million by 2032, rising at a market growth of 4.1% CAGR during the forecast period (2026-2032).
Equine Immunoglobulin and F(ab')2 Fragment Products refer to a class of passive immunotherapy biologics derived from hyperimmune horse plasma obtained after immunization with venoms, bacterial toxins, viral antigens, or related immunogens, followed by purification, enzymatic digestion, viral inactivation, formulation, and sterile filling. Major commercial products include snake antivenoms, equine tetanus immunoglobulin, equine rabies immunoglobulin, and selected antitoxin preparations. Upstream raw materials and inputs mainly include immunized horses, venoms or toxoids/antigens, plasma collection and fractionation materials, enzymes, purification reagents, stabilizers, packaging materials, and cold-chain logistics, while downstream customers are primarily hospital emergency departments, trauma treatment centers, envenomation treatment institutions, public health agencies, and government stockpile systems. The global production capacity for equine immunoglobulin and F(ab')2 products is estimated at approximately 19.4 million vials in 2025, with sales volume of about 15.68 million vials, an average ex-factory price of around US$92 per vial, and gross margins generally in the range of 45%?72%. Overall, this market is characterized by strong regionalization and indication-specific segmentation: developing markets are dominated by high-volume, lower-priced demand, whereas developed markets are more strongly driven by specialized clinical use and public health stockpiling, resulting in higher value-added product demand.
This report studies the global Equine Immunoglobulin and F(ab')2 Products production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Equine Immunoglobulin and F(ab')2 Products and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Equine Immunoglobulin and F(ab')2 Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Equine Immunoglobulin and F(ab')2 Products total production and demand, 2021-2032, (K Units)
Global Equine Immunoglobulin and F(ab')2 Products total production value, 2021-2032, (USD Million)
Global Equine Immunoglobulin and F(ab')2 Products production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Equine Immunoglobulin and F(ab')2 Products consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Equine Immunoglobulin and F(ab')2 Products domestic production, consumption, key domestic manufacturers and share
Global Equine Immunoglobulin and F(ab')2 Products production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Equine Immunoglobulin and F(ab')2 Products production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Equine Immunoglobulin and F(ab')2 Products production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Equine Immunoglobulin and F(ab')2 Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Laboratorios Silanes, Emergent BioSolutions, Shanghai Serum Bio-Technology, VINS Bioproducts, Bharat Serums and Vaccines, KM Biologics, Inosan Biopharma, MicroPharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Equine Immunoglobulin and F(ab')2 Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Equine Immunoglobulin and F(ab')2 Products Market, By Region:
1. How big is the global Equine Immunoglobulin and F(ab')2 Products market?
2. What is the demand of the global Equine Immunoglobulin and F(ab')2 Products market?
3. What is the year over year growth of the global Equine Immunoglobulin and F(ab')2 Products market?
4. What is the production and production value of the global Equine Immunoglobulin and F(ab')2 Products market?
5. Who are the key producers in the global Equine Immunoglobulin and F(ab')2 Products market?
6. What are the growth factors driving the market demand?
Equine Immunoglobulin and F(ab')2 Fragment Products refer to a class of passive immunotherapy biologics derived from hyperimmune horse plasma obtained after immunization with venoms, bacterial toxins, viral antigens, or related immunogens, followed by purification, enzymatic digestion, viral inactivation, formulation, and sterile filling. Major commercial products include snake antivenoms, equine tetanus immunoglobulin, equine rabies immunoglobulin, and selected antitoxin preparations. Upstream raw materials and inputs mainly include immunized horses, venoms or toxoids/antigens, plasma collection and fractionation materials, enzymes, purification reagents, stabilizers, packaging materials, and cold-chain logistics, while downstream customers are primarily hospital emergency departments, trauma treatment centers, envenomation treatment institutions, public health agencies, and government stockpile systems. The global production capacity for equine immunoglobulin and F(ab')2 products is estimated at approximately 19.4 million vials in 2025, with sales volume of about 15.68 million vials, an average ex-factory price of around US$92 per vial, and gross margins generally in the range of 45%?72%. Overall, this market is characterized by strong regionalization and indication-specific segmentation: developing markets are dominated by high-volume, lower-priced demand, whereas developed markets are more strongly driven by specialized clinical use and public health stockpiling, resulting in higher value-added product demand.
This report studies the global Equine Immunoglobulin and F(ab')2 Products production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Equine Immunoglobulin and F(ab')2 Products and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Equine Immunoglobulin and F(ab')2 Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Equine Immunoglobulin and F(ab')2 Products total production and demand, 2021-2032, (K Units)
Global Equine Immunoglobulin and F(ab')2 Products total production value, 2021-2032, (USD Million)
Global Equine Immunoglobulin and F(ab')2 Products production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Equine Immunoglobulin and F(ab')2 Products consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Equine Immunoglobulin and F(ab')2 Products domestic production, consumption, key domestic manufacturers and share
Global Equine Immunoglobulin and F(ab')2 Products production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Equine Immunoglobulin and F(ab')2 Products production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Equine Immunoglobulin and F(ab')2 Products production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Equine Immunoglobulin and F(ab')2 Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Laboratorios Silanes, Emergent BioSolutions, Shanghai Serum Bio-Technology, VINS Bioproducts, Bharat Serums and Vaccines, KM Biologics, Inosan Biopharma, MicroPharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Equine Immunoglobulin and F(ab')2 Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Equine Immunoglobulin and F(ab')2 Products Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tetanus Antitoxins
- Snake Antivenoms
- Anti-rabies Sera
- Other
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Others
- Laboratorios Silanes
- Emergent BioSolutions
- Shanghai Serum Bio-Technology
- VINS Bioproducts
- Bharat Serums and Vaccines
- KM Biologics
- Inosan Biopharma
- MicroPharm
1. How big is the global Equine Immunoglobulin and F(ab')2 Products market?
2. What is the demand of the global Equine Immunoglobulin and F(ab')2 Products market?
3. What is the year over year growth of the global Equine Immunoglobulin and F(ab')2 Products market?
4. What is the production and production value of the global Equine Immunoglobulin and F(ab')2 Products market?
5. Who are the key producers in the global Equine Immunoglobulin and F(ab')2 Products market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Equine Immunoglobulin and F(ab')2 Products Introduction
1.2 World Equine Immunoglobulin and F(ab')2 Products Supply & Forecast
1.2.1 World Equine Immunoglobulin and F(ab')2 Products Production Value (2021 & 2025 & 2032)
1.2.2 World Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.2.3 World Equine Immunoglobulin and F(ab')2 Products Pricing Trends (2021-2032)
1.3 World Equine Immunoglobulin and F(ab')2 Products Production by Region (Based on Production Site)
1.3.1 World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021-2032)
1.3.2 World Equine Immunoglobulin and F(ab')2 Products Production by Region (2021-2032)
1.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2021-2032)
1.3.4 North America Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.5 Europe Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.6 China Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.7 Japan Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Equine Immunoglobulin and F(ab')2 Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Equine Immunoglobulin and F(ab')2 Products Major Market Trends
2 DEMAND SUMMARY
2.1 World Equine Immunoglobulin and F(ab')2 Products Demand (2021-2032)
2.2 World Equine Immunoglobulin and F(ab')2 Products Consumption by Region
2.2.1 World Equine Immunoglobulin and F(ab')2 Products Consumption by Region (2021-2026)
2.2.2 World Equine Immunoglobulin and F(ab')2 Products Consumption Forecast by Region (2027-2032)
2.3 United States Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.4 China Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.5 Europe Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.6 Japan Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.7 South Korea Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.8 ASEAN Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.9 India Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Equine Immunoglobulin and F(ab')2 Products Production Value by Manufacturer (2021-2026)
3.2 World Equine Immunoglobulin and F(ab')2 Products Production by Manufacturer (2021-2026)
3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Manufacturer (2021-2026)
3.4 Equine Immunoglobulin and F(ab')2 Products Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Equine Immunoglobulin and F(ab')2 Products Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Equine Immunoglobulin and F(ab')2 Products in 2025
3.5.3 Global Concentration Ratios (CR8) for Equine Immunoglobulin and F(ab')2 Products in 2025
3.6 Equine Immunoglobulin and F(ab')2 Products Market: Overall Company Footprint Analysis
3.6.1 Equine Immunoglobulin and F(ab')2 Products Market: Region Footprint
3.6.2 Equine Immunoglobulin and F(ab')2 Products Market: Company Product Type Footprint
3.6.3 Equine Immunoglobulin and F(ab')2 Products Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Comparison
4.1.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Comparison
4.2.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Comparison
4.3.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.4.3 United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
4.5 China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share
4.5.1 China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.5.3 China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
4.6 Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tetanus Antitoxins
5.2.2 Snake Antivenoms
5.2.3 Anti-rabies Sera
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Type (2021-2032)
5.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2021-2032)
5.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channels
6.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2021-2032)
6.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2021-2032)
6.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Application (2021-2032)
7.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2021-2032)
7.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Laboratorios Silanes
8.1.1 Laboratorios Silanes Details
8.1.2 Laboratorios Silanes Major Business
8.1.3 Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Product and Services
8.1.4 Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Laboratorios Silanes Recent Developments/Updates
8.1.6 Laboratorios Silanes Competitive Strengths & Weaknesses
8.2 Emergent BioSolutions
8.2.1 Emergent BioSolutions Details
8.2.2 Emergent BioSolutions Major Business
8.2.3 Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Product and Services
8.2.4 Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Emergent BioSolutions Recent Developments/Updates
8.2.6 Emergent BioSolutions Competitive Strengths & Weaknesses
8.3 Shanghai Serum Bio-Technology
8.3.1 Shanghai Serum Bio-Technology Details
8.3.2 Shanghai Serum Bio-Technology Major Business
8.3.3 Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Product and Services
8.3.4 Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Shanghai Serum Bio-Technology Recent Developments/Updates
8.3.6 Shanghai Serum Bio-Technology Competitive Strengths & Weaknesses
8.4 VINS Bioproducts
8.4.1 VINS Bioproducts Details
8.4.2 VINS Bioproducts Major Business
8.4.3 VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Product and Services
8.4.4 VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 VINS Bioproducts Recent Developments/Updates
8.4.6 VINS Bioproducts Competitive Strengths & Weaknesses
8.5 Bharat Serums and Vaccines
8.5.1 Bharat Serums and Vaccines Details
8.5.2 Bharat Serums and Vaccines Major Business
8.5.3 Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Product and Services
8.5.4 Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Bharat Serums and Vaccines Recent Developments/Updates
8.5.6 Bharat Serums and Vaccines Competitive Strengths & Weaknesses
8.6 KM Biologics
8.6.1 KM Biologics Details
8.6.2 KM Biologics Major Business
8.6.3 KM Biologics Equine Immunoglobulin and F(ab')2 Products Product and Services
8.6.4 KM Biologics Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 KM Biologics Recent Developments/Updates
8.6.6 KM Biologics Competitive Strengths & Weaknesses
8.7 Inosan Biopharma
8.7.1 Inosan Biopharma Details
8.7.2 Inosan Biopharma Major Business
8.7.3 Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Product and Services
8.7.4 Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Inosan Biopharma Recent Developments/Updates
8.7.6 Inosan Biopharma Competitive Strengths & Weaknesses
8.8 MicroPharm
8.8.1 MicroPharm Details
8.8.2 MicroPharm Major Business
8.8.3 MicroPharm Equine Immunoglobulin and F(ab')2 Products Product and Services
8.8.4 MicroPharm Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 MicroPharm Recent Developments/Updates
8.8.6 MicroPharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Equine Immunoglobulin and F(ab')2 Products Industry Chain
9.2 Equine Immunoglobulin and F(ab')2 Products Upstream Analysis
9.2.1 Equine Immunoglobulin and F(ab')2 Products Core Raw Materials
9.2.2 Main Manufacturers of Equine Immunoglobulin and F(ab')2 Products Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Equine Immunoglobulin and F(ab')2 Products Production Mode
9.6 Equine Immunoglobulin and F(ab')2 Products Procurement Model
9.7 Equine Immunoglobulin and F(ab')2 Products Industry Sales Model and Sales Channels
9.7.1 Equine Immunoglobulin and F(ab')2 Products Sales Model
9.7.2 Equine Immunoglobulin and F(ab')2 Products Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Equine Immunoglobulin and F(ab')2 Products Introduction
1.2 World Equine Immunoglobulin and F(ab')2 Products Supply & Forecast
1.2.1 World Equine Immunoglobulin and F(ab')2 Products Production Value (2021 & 2025 & 2032)
1.2.2 World Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.2.3 World Equine Immunoglobulin and F(ab')2 Products Pricing Trends (2021-2032)
1.3 World Equine Immunoglobulin and F(ab')2 Products Production by Region (Based on Production Site)
1.3.1 World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021-2032)
1.3.2 World Equine Immunoglobulin and F(ab')2 Products Production by Region (2021-2032)
1.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2021-2032)
1.3.4 North America Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.5 Europe Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.6 China Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.3.7 Japan Equine Immunoglobulin and F(ab')2 Products Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Equine Immunoglobulin and F(ab')2 Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Equine Immunoglobulin and F(ab')2 Products Major Market Trends
2 DEMAND SUMMARY
2.1 World Equine Immunoglobulin and F(ab')2 Products Demand (2021-2032)
2.2 World Equine Immunoglobulin and F(ab')2 Products Consumption by Region
2.2.1 World Equine Immunoglobulin and F(ab')2 Products Consumption by Region (2021-2026)
2.2.2 World Equine Immunoglobulin and F(ab')2 Products Consumption Forecast by Region (2027-2032)
2.3 United States Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.4 China Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.5 Europe Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.6 Japan Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.7 South Korea Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.8 ASEAN Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
2.9 India Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Equine Immunoglobulin and F(ab')2 Products Production Value by Manufacturer (2021-2026)
3.2 World Equine Immunoglobulin and F(ab')2 Products Production by Manufacturer (2021-2026)
3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Manufacturer (2021-2026)
3.4 Equine Immunoglobulin and F(ab')2 Products Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Equine Immunoglobulin and F(ab')2 Products Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Equine Immunoglobulin and F(ab')2 Products in 2025
3.5.3 Global Concentration Ratios (CR8) for Equine Immunoglobulin and F(ab')2 Products in 2025
3.6 Equine Immunoglobulin and F(ab')2 Products Market: Overall Company Footprint Analysis
3.6.1 Equine Immunoglobulin and F(ab')2 Products Market: Region Footprint
3.6.2 Equine Immunoglobulin and F(ab')2 Products Market: Company Product Type Footprint
3.6.3 Equine Immunoglobulin and F(ab')2 Products Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Comparison
4.1.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Comparison
4.2.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Comparison
4.3.1 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.4.3 United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
4.5 China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share
4.5.1 China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.5.3 China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
4.6 Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tetanus Antitoxins
5.2.2 Snake Antivenoms
5.2.3 Anti-rabies Sera
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Type (2021-2032)
5.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2021-2032)
5.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channels
6.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2021-2032)
6.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2021-2032)
6.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Equine Immunoglobulin and F(ab')2 Products Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Equine Immunoglobulin and F(ab')2 Products Production by Application (2021-2032)
7.3.2 World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2021-2032)
7.3.3 World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Laboratorios Silanes
8.1.1 Laboratorios Silanes Details
8.1.2 Laboratorios Silanes Major Business
8.1.3 Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Product and Services
8.1.4 Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Laboratorios Silanes Recent Developments/Updates
8.1.6 Laboratorios Silanes Competitive Strengths & Weaknesses
8.2 Emergent BioSolutions
8.2.1 Emergent BioSolutions Details
8.2.2 Emergent BioSolutions Major Business
8.2.3 Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Product and Services
8.2.4 Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Emergent BioSolutions Recent Developments/Updates
8.2.6 Emergent BioSolutions Competitive Strengths & Weaknesses
8.3 Shanghai Serum Bio-Technology
8.3.1 Shanghai Serum Bio-Technology Details
8.3.2 Shanghai Serum Bio-Technology Major Business
8.3.3 Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Product and Services
8.3.4 Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Shanghai Serum Bio-Technology Recent Developments/Updates
8.3.6 Shanghai Serum Bio-Technology Competitive Strengths & Weaknesses
8.4 VINS Bioproducts
8.4.1 VINS Bioproducts Details
8.4.2 VINS Bioproducts Major Business
8.4.3 VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Product and Services
8.4.4 VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 VINS Bioproducts Recent Developments/Updates
8.4.6 VINS Bioproducts Competitive Strengths & Weaknesses
8.5 Bharat Serums and Vaccines
8.5.1 Bharat Serums and Vaccines Details
8.5.2 Bharat Serums and Vaccines Major Business
8.5.3 Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Product and Services
8.5.4 Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Bharat Serums and Vaccines Recent Developments/Updates
8.5.6 Bharat Serums and Vaccines Competitive Strengths & Weaknesses
8.6 KM Biologics
8.6.1 KM Biologics Details
8.6.2 KM Biologics Major Business
8.6.3 KM Biologics Equine Immunoglobulin and F(ab')2 Products Product and Services
8.6.4 KM Biologics Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 KM Biologics Recent Developments/Updates
8.6.6 KM Biologics Competitive Strengths & Weaknesses
8.7 Inosan Biopharma
8.7.1 Inosan Biopharma Details
8.7.2 Inosan Biopharma Major Business
8.7.3 Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Product and Services
8.7.4 Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Inosan Biopharma Recent Developments/Updates
8.7.6 Inosan Biopharma Competitive Strengths & Weaknesses
8.8 MicroPharm
8.8.1 MicroPharm Details
8.8.2 MicroPharm Major Business
8.8.3 MicroPharm Equine Immunoglobulin and F(ab')2 Products Product and Services
8.8.4 MicroPharm Equine Immunoglobulin and F(ab')2 Products Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 MicroPharm Recent Developments/Updates
8.8.6 MicroPharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Equine Immunoglobulin and F(ab')2 Products Industry Chain
9.2 Equine Immunoglobulin and F(ab')2 Products Upstream Analysis
9.2.1 Equine Immunoglobulin and F(ab')2 Products Core Raw Materials
9.2.2 Main Manufacturers of Equine Immunoglobulin and F(ab')2 Products Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Equine Immunoglobulin and F(ab')2 Products Production Mode
9.6 Equine Immunoglobulin and F(ab')2 Products Procurement Model
9.7 Equine Immunoglobulin and F(ab')2 Products Industry Sales Model and Sales Channels
9.7.1 Equine Immunoglobulin and F(ab')2 Products Sales Model
9.7.2 Equine Immunoglobulin and F(ab')2 Products Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021-2026) & (USD Million)
Table 3. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2027-2032) & (USD Million)
Table 4. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2021-2026)
Table 5. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2027-2032)
Table 6. World Equine Immunoglobulin and F(ab')2 Products Production by Region (2021-2026) & (K Units)
Table 7. World Equine Immunoglobulin and F(ab')2 Products Production by Region (2027-2032) & (K Units)
Table 8. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2021-2026)
Table 9. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2027-2032)
Table 10. World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Equine Immunoglobulin and F(ab')2 Products Major Market Trends
Table 13. World Equine Immunoglobulin and F(ab')2 Products Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Equine Immunoglobulin and F(ab')2 Products Consumption by Region (2021-2026) & (K Units)
Table 15. World Equine Immunoglobulin and F(ab')2 Products Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Equine Immunoglobulin and F(ab')2 Products Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Equine Immunoglobulin and F(ab')2 Products Producers in 2025
Table 18. World Equine Immunoglobulin and F(ab')2 Products Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Equine Immunoglobulin and F(ab')2 Products Producers in 2025
Table 20. World Equine Immunoglobulin and F(ab')2 Products Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Equine Immunoglobulin and F(ab')2 Products Company Evaluation Quadrant
Table 22. World Equine Immunoglobulin and F(ab')2 Products Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Equine Immunoglobulin and F(ab')2 Products Production Site of Key Manufacturer
Table 24. Equine Immunoglobulin and F(ab')2 Products Market: Company Product Type Footprint
Table 25. Equine Immunoglobulin and F(ab')2 Products Market: Company Product Application Footprint
Table 26. Equine Immunoglobulin and F(ab')2 Products Competitive Factors
Table 27. Equine Immunoglobulin and F(ab')2 Products New Entrant and Capacity Expansion Plans
Table 28. Equine Immunoglobulin and F(ab')2 Products Mergers & Acquisitions Activity
Table 29. United States VS China Equine Immunoglobulin and F(ab')2 Products Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Equine Immunoglobulin and F(ab')2 Products Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Equine Immunoglobulin and F(ab')2 Products Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 37. China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 42. Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 47. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Equine Immunoglobulin and F(ab')2 Products Production by Type (2021-2026) & (K Units)
Table 49. World Equine Immunoglobulin and F(ab')2 Products Production by Type (2027-2032) & (K Units)
Table 50. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2021-2026) & (USD Million)
Table 51. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2027-2032) & (USD Million)
Table 52. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2021-2026) & (K Units)
Table 56. World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2027-2032) & (K Units)
Table 57. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Equine Immunoglobulin and F(ab')2 Products Production by Application (2021-2026) & (K Units)
Table 63. World Equine Immunoglobulin and F(ab')2 Products Production by Application (2027-2032) & (K Units)
Table 64. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2021-2026) & (USD Million)
Table 65. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2027-2032) & (USD Million)
Table 66. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Laboratorios Silanes Basic Information, Manufacturing Base and Competitors
Table 69. Laboratorios Silanes Major Business
Table 70. Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 71. Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Laboratorios Silanes Recent Developments/Updates
Table 73. Laboratorios Silanes Competitive Strengths & Weaknesses
Table 74. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 75. Emergent BioSolutions Major Business
Table 76. Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 77. Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Emergent BioSolutions Recent Developments/Updates
Table 79. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 80. Shanghai Serum Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 81. Shanghai Serum Bio-Technology Major Business
Table 82. Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 83. Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shanghai Serum Bio-Technology Recent Developments/Updates
Table 85. Shanghai Serum Bio-Technology Competitive Strengths & Weaknesses
Table 86. VINS Bioproducts Basic Information, Manufacturing Base and Competitors
Table 87. VINS Bioproducts Major Business
Table 88. VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 89. VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. VINS Bioproducts Recent Developments/Updates
Table 91. VINS Bioproducts Competitive Strengths & Weaknesses
Table 92. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 93. Bharat Serums and Vaccines Major Business
Table 94. Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 95. Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Bharat Serums and Vaccines Recent Developments/Updates
Table 97. Bharat Serums and Vaccines Competitive Strengths & Weaknesses
Table 98. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 99. KM Biologics Major Business
Table 100. KM Biologics Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 101. KM Biologics Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. KM Biologics Recent Developments/Updates
Table 103. KM Biologics Competitive Strengths & Weaknesses
Table 104. Inosan Biopharma Basic Information, Manufacturing Base and Competitors
Table 105. Inosan Biopharma Major Business
Table 106. Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 107. Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Inosan Biopharma Recent Developments/Updates
Table 109. Inosan Biopharma Competitive Strengths & Weaknesses
Table 110. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 111. MicroPharm Major Business
Table 112. MicroPharm Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 113. MicroPharm Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. MicroPharm Recent Developments/Updates
Table 115. MicroPharm Competitive Strengths & Weaknesses
Table 116. Global Key Players of Equine Immunoglobulin and F(ab')2 Products Upstream (Raw Materials)
Table 117. Global Equine Immunoglobulin and F(ab')2 Products Typical Customers
Table 118. Equine Immunoglobulin and F(ab')2 Products Typical Distributors
Table 1. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2021-2026) & (USD Million)
Table 3. World Equine Immunoglobulin and F(ab')2 Products Production Value by Region (2027-2032) & (USD Million)
Table 4. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2021-2026)
Table 5. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2027-2032)
Table 6. World Equine Immunoglobulin and F(ab')2 Products Production by Region (2021-2026) & (K Units)
Table 7. World Equine Immunoglobulin and F(ab')2 Products Production by Region (2027-2032) & (K Units)
Table 8. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2021-2026)
Table 9. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2027-2032)
Table 10. World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Equine Immunoglobulin and F(ab')2 Products Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Equine Immunoglobulin and F(ab')2 Products Major Market Trends
Table 13. World Equine Immunoglobulin and F(ab')2 Products Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Equine Immunoglobulin and F(ab')2 Products Consumption by Region (2021-2026) & (K Units)
Table 15. World Equine Immunoglobulin and F(ab')2 Products Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Equine Immunoglobulin and F(ab')2 Products Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Equine Immunoglobulin and F(ab')2 Products Producers in 2025
Table 18. World Equine Immunoglobulin and F(ab')2 Products Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Equine Immunoglobulin and F(ab')2 Products Producers in 2025
Table 20. World Equine Immunoglobulin and F(ab')2 Products Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Equine Immunoglobulin and F(ab')2 Products Company Evaluation Quadrant
Table 22. World Equine Immunoglobulin and F(ab')2 Products Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Equine Immunoglobulin and F(ab')2 Products Production Site of Key Manufacturer
Table 24. Equine Immunoglobulin and F(ab')2 Products Market: Company Product Type Footprint
Table 25. Equine Immunoglobulin and F(ab')2 Products Market: Company Product Application Footprint
Table 26. Equine Immunoglobulin and F(ab')2 Products Competitive Factors
Table 27. Equine Immunoglobulin and F(ab')2 Products New Entrant and Capacity Expansion Plans
Table 28. Equine Immunoglobulin and F(ab')2 Products Mergers & Acquisitions Activity
Table 29. United States VS China Equine Immunoglobulin and F(ab')2 Products Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Equine Immunoglobulin and F(ab')2 Products Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Equine Immunoglobulin and F(ab')2 Products Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 37. China Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 42. Rest of World Based Equine Immunoglobulin and F(ab')2 Products Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share (2021-2026)
Table 47. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Equine Immunoglobulin and F(ab')2 Products Production by Type (2021-2026) & (K Units)
Table 49. World Equine Immunoglobulin and F(ab')2 Products Production by Type (2027-2032) & (K Units)
Table 50. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2021-2026) & (USD Million)
Table 51. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type (2027-2032) & (USD Million)
Table 52. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2021-2026) & (K Units)
Table 56. World Equine Immunoglobulin and F(ab')2 Products Production by Sales Channels (2027-2032) & (K Units)
Table 57. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Equine Immunoglobulin and F(ab')2 Products Production by Application (2021-2026) & (K Units)
Table 63. World Equine Immunoglobulin and F(ab')2 Products Production by Application (2027-2032) & (K Units)
Table 64. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2021-2026) & (USD Million)
Table 65. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application (2027-2032) & (USD Million)
Table 66. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Laboratorios Silanes Basic Information, Manufacturing Base and Competitors
Table 69. Laboratorios Silanes Major Business
Table 70. Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 71. Laboratorios Silanes Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Laboratorios Silanes Recent Developments/Updates
Table 73. Laboratorios Silanes Competitive Strengths & Weaknesses
Table 74. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 75. Emergent BioSolutions Major Business
Table 76. Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 77. Emergent BioSolutions Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Emergent BioSolutions Recent Developments/Updates
Table 79. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 80. Shanghai Serum Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 81. Shanghai Serum Bio-Technology Major Business
Table 82. Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 83. Shanghai Serum Bio-Technology Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shanghai Serum Bio-Technology Recent Developments/Updates
Table 85. Shanghai Serum Bio-Technology Competitive Strengths & Weaknesses
Table 86. VINS Bioproducts Basic Information, Manufacturing Base and Competitors
Table 87. VINS Bioproducts Major Business
Table 88. VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 89. VINS Bioproducts Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. VINS Bioproducts Recent Developments/Updates
Table 91. VINS Bioproducts Competitive Strengths & Weaknesses
Table 92. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 93. Bharat Serums and Vaccines Major Business
Table 94. Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 95. Bharat Serums and Vaccines Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Bharat Serums and Vaccines Recent Developments/Updates
Table 97. Bharat Serums and Vaccines Competitive Strengths & Weaknesses
Table 98. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 99. KM Biologics Major Business
Table 100. KM Biologics Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 101. KM Biologics Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. KM Biologics Recent Developments/Updates
Table 103. KM Biologics Competitive Strengths & Weaknesses
Table 104. Inosan Biopharma Basic Information, Manufacturing Base and Competitors
Table 105. Inosan Biopharma Major Business
Table 106. Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 107. Inosan Biopharma Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Inosan Biopharma Recent Developments/Updates
Table 109. Inosan Biopharma Competitive Strengths & Weaknesses
Table 110. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 111. MicroPharm Major Business
Table 112. MicroPharm Equine Immunoglobulin and F(ab')2 Products Product and Services
Table 113. MicroPharm Equine Immunoglobulin and F(ab')2 Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. MicroPharm Recent Developments/Updates
Table 115. MicroPharm Competitive Strengths & Weaknesses
Table 116. Global Key Players of Equine Immunoglobulin and F(ab')2 Products Upstream (Raw Materials)
Table 117. Global Equine Immunoglobulin and F(ab')2 Products Typical Customers
Table 118. Equine Immunoglobulin and F(ab')2 Products Typical Distributors
LIST OF FIGURES
Figure 1. Equine Immunoglobulin and F(ab')2 Products Picture
Figure 2. World Equine Immunoglobulin and F(ab')2 Products Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Equine Immunoglobulin and F(ab')2 Products Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 5. World Equine Immunoglobulin and F(ab')2 Products Average Price (2021-2032) & (US$/Unit)
Figure 6. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2021-2032)
Figure 7. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2021-2032)
Figure 8. North America Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 9. Europe Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 10. China Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 11. Japan Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 12. Equine Immunoglobulin and F(ab')2 Products Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 15. World Equine Immunoglobulin and F(ab')2 Products Consumption Market Share by Region (2021-2032)
Figure 16. United States Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 17. China Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 18. Europe Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 19. Japan Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 20. South Korea Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 22. India Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Equine Immunoglobulin and F(ab')2 Products by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Equine Immunoglobulin and F(ab')2 Products Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Equine Immunoglobulin and F(ab')2 Products Markets in 2025
Figure 26. United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 30. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 32. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Type in 2025
Figure 34. Tetanus Antitoxins
Figure 35. Snake Antivenoms
Figure 36. Anti-rabies Sera
Figure 37. Other
Figure 38. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Type (2021-2032)
Figure 39. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Type (2021-2032)
Figure 40. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 42. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Sales Channels in 2025
Figure 43. Online Sales
Figure 44. Offline Sales
Figure 45. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Sales Channels (2021-2032)
Figure 46. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Application in 2025
Figure 50. Hospital
Figure 51. Clinic
Figure 52. Others
Figure 53. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Application (2021-2032)
Figure 54. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Application (2021-2032)
Figure 55. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2032) & (US$/Unit)
Figure 56. Equine Immunoglobulin and F(ab')2 Products Industry Chain
Figure 57. Equine Immunoglobulin and F(ab')2 Products Procurement Model
Figure 58. Equine Immunoglobulin and F(ab')2 Products Sales Model
Figure 59. Equine Immunoglobulin and F(ab')2 Products Sales Channels, Direct Sales, and Distribution
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. Equine Immunoglobulin and F(ab')2 Products Picture
Figure 2. World Equine Immunoglobulin and F(ab')2 Products Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Equine Immunoglobulin and F(ab')2 Products Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 5. World Equine Immunoglobulin and F(ab')2 Products Average Price (2021-2032) & (US$/Unit)
Figure 6. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Region (2021-2032)
Figure 7. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Region (2021-2032)
Figure 8. North America Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 9. Europe Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 10. China Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 11. Japan Equine Immunoglobulin and F(ab')2 Products Production (2021-2032) & (K Units)
Figure 12. Equine Immunoglobulin and F(ab')2 Products Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 15. World Equine Immunoglobulin and F(ab')2 Products Consumption Market Share by Region (2021-2032)
Figure 16. United States Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 17. China Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 18. Europe Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 19. Japan Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 20. South Korea Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 22. India Equine Immunoglobulin and F(ab')2 Products Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Equine Immunoglobulin and F(ab')2 Products by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Equine Immunoglobulin and F(ab')2 Products Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Equine Immunoglobulin and F(ab')2 Products Markets in 2025
Figure 26. United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Equine Immunoglobulin and F(ab')2 Products Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Equine Immunoglobulin and F(ab')2 Products Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 30. China Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Equine Immunoglobulin and F(ab')2 Products Production Market Share 2025
Figure 32. World Equine Immunoglobulin and F(ab')2 Products Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Type in 2025
Figure 34. Tetanus Antitoxins
Figure 35. Snake Antivenoms
Figure 36. Anti-rabies Sera
Figure 37. Other
Figure 38. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Type (2021-2032)
Figure 39. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Type (2021-2032)
Figure 40. World Equine Immunoglobulin and F(ab')2 Products Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Equine Immunoglobulin and F(ab')2 Products Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 42. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Sales Channels in 2025
Figure 43. Online Sales
Figure 44. Offline Sales
Figure 45. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Sales Channels (2021-2032)
Figure 46. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Equine Immunoglobulin and F(ab')2 Products Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48. World Equine Immunoglobulin and F(ab')2 Products Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Application in 2025
Figure 50. Hospital
Figure 51. Clinic
Figure 52. Others
Figure 53. World Equine Immunoglobulin and F(ab')2 Products Production Market Share by Application (2021-2032)
Figure 54. World Equine Immunoglobulin and F(ab')2 Products Production Value Market Share by Application (2021-2032)
Figure 55. World Equine Immunoglobulin and F(ab')2 Products Average Price by Application (2021-2032) & (US$/Unit)
Figure 56. Equine Immunoglobulin and F(ab')2 Products Industry Chain
Figure 57. Equine Immunoglobulin and F(ab')2 Products Procurement Model
Figure 58. Equine Immunoglobulin and F(ab')2 Products Sales Model
Figure 59. Equine Immunoglobulin and F(ab')2 Products Sales Channels, Direct Sales, and Distribution
Figure 60. Methodology
Figure 61. Research Process and Data Source
